Target intelligence / Profile preview

Pathogenic cell

Molecular classification
Other
01

Overview

The term "Pathogenic cells" refers to a broad category of biological entities that cause disease, including exogenous infectious agents like bacteria, fungi, and parasites, as well as endogenous host cells that have become harmful, such as cancer cells or autoreactive immune cells [1][2]. Because it describes an entire cell rather than a specific molecule, it is not considered a single therapeutic target in the traditional sense; instead, these cells contain numerous specific receptors, enzymes, and structural proteins that serve as targets for drug development [3]. In infectious diseases, pathogenic cells invade host tissues and utilize various virulence factors to bypass immune defenses and replicate [2][4]. In oncology, these cells are characterized by genomic instability and uncontrolled proliferation, often requiring targeted therapies like monoclonal antibodies or small molecule inhibitors to achieve selective elimination [1][5]. Effective treatment strategies focus on identifying unique biochemical or structural differences between the pathogenic cell and healthy host cells to minimize collateral damage [3][4].

Other names
Diseased cellInfectious agentMalignant cellHarmful microorganismPathogen
02

Mechanism of action

Drugs typically target specific molecular components within pathogenic cells, such as inhibiting cell wall synthesis, disrupting DNA replication, blocking protein synthesis, or inducing programmed cell death (apoptosis).

03

Biological functions

PathogenesisCell proliferationImmune evasionToxin productionMetabolic disruptionReplication
04

Disease associations

InfectionCancerAutoimmune diseaseInflammationNeurodegenerative disease
05

Safety considerations

Off-target toxicity to healthy host cellsDevelopment of drug resistance (e.g., antimicrobial resistance)Cytokine release syndromeDisruption of commensal microbiome
06

Interacting drugs

Penicillin

5 more in the full profile.

07

Biomarkers

Cell surface antigens (e.g., CD20, HER2)Circulating tumor DNA (ctDNA)Pathogen-specific nucleic acids (DNA/RNA)Specific metabolites

Beyond the preview

Go deeper on Pathogenic cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call